Tag: Aspirin
New Stroke Risk Down With Clopidogrel-Aspirin Initiated Within 72 Hours
Findings seen among patients with mild ischemic stroke or high-risk transient ischemic attack of presumed atherosclerotic cause
AHA: Avoidance of Aspirin Noninferior With LVAD in Advanced Heart Failure
Findings seen among patients with advanced heart failure receiving support from a fully magnetically levitated left ventricular assist device
TCT: Ticagrelor Monotherapy Within One Month of DAPT Noninferior to Continued DAPT
Major bleeding occurred in fewer patients in group receiving ticagrelor monotherapy after less than one month of DAPT versus 12-month DAPT group
ACG: Prophylactic Low-Dose Aspirin in Pregnancy Does Not Increase IBD Activity
Findings seen among pregnant patients with inflammatory bowel disease
Enteric-Coated, Uncoated Aspirin Have Similar Effectiveness in Heart Patients
Findings seen for secondary prevention among patients with cardiovascular disease
EASD: Low-Dose Aspirin Tied to Lower Risk for New Diabetes in Older Adults
Findings show low-dose aspirin also slows the increase in fasting plasma glucose over time among initially healthy older adults
ESC: Adverse Outcomes Increased With Suboptimal Adherence to Aspirin After MI
Risk increased for recurrent MI, ischemic stroke, or death with suboptimal adherence through eight years after MI
Aspirin Underused in Secondary Prevention of Cardiovascular Disease
Estimates of use increased from 16.6 percent in low-income countries to 65.0 percent in high-income countries
Low-Dose Aspirin Does Not Cut Incidence of Ischemic Stroke in Seniors
But significant increase in intracranial bleeding seen for those receiving aspirin versus placebo
P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
Reduced risk seen for composite of cardiovascular death, myocardial infarction, and stroke
